Myths and mysteries surrounding bacillus Calmette-Guérin therapy for bladder cancer
1Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
European Urology
|November 9, 2013
Abstract:
Intravesical therapy with bacillus Calmette-Guérin has proven effects for reducing recurrence, progression, and death from non-muscle-invasive bladder cancer. These advantages are seen mainly when appropriate maintenance therapy is used for 1-3 years, in the context of appropriate patient selection, tumor management, and symptom support for potential side effects.
